NEOVACS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 EUR | -.--% |
|
-.--% | -.--% |
| 05-29 | Neovacs: mRNA approach validated in preclinical trial | CF |
| 05-27 | Neovacs: collaboration contract with INSERM team | CF |
Performance
| 3 months | -99.04% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
50 641
Capitalization (USD)
54 920
Net sales (EUR)
533 412
Net sales (USD)
578 485
Free-Float
0.12 %
Free-Float capitalization (EUR)
0
Free-Float capitalization (USD)
0
Highs and lows
1 week
0.00
5.00
1 month
0.0010.00
Indicators
Moving average 5 days
5.00
Moving average 100 days
884.44
Price spread / (MMA5)
+999,900.00%
Price spread / (MMA100)
+176,888,780.00%
RSI 9 days
0.00
RSI 14 days
0.00
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
- Stock Market
- Equities
- ALNEV Stock
- 0LW Stock
- Quotes NEOVACS SA
